Company Update: Medtronic Inc (NYSE:MDT) – Medtronic plans new study of blood pressure-lowering device

[Reuters] – Medical device maker Medtronic Plc said on Tuesday it planned to seek approval from U.S. regulators to begin a new study of its version of a hypertension treatment in which nerve . . . → Read More: Company Update: Medtronic Inc (NYSE:MDT) – Medtronic plans new study of blood pressure-lowering device Similar Articles: Company Update (NYSE:MDT): Medtronic Study Reveals Significant Heart Rhythm Disorders Occurring in Patients Undergoing Hemodialysis Market Update: Medtronic Inc (NYSE:MDT) – Medtronic seeks EU approval for $43 bln Covidien deal Stock Update (NYSE:BSX): FDA panel offers mixed view on Boston Scientific Watchman device